Comparison of the performance of the prognostic marker panel (10 –fold cross validation [CV] and permutated model), generated using CV test for the best combos of prognostic markers.

figure

posted on 2024-06-13, 17:36 authored by Nirmali Samarakoon, Thashi Chang, Vimukthi Gunasekara, Praneeth Ratnayake, Rasika Jayatillake, Preethi Udagama

History

Usage metrics

Keywords

xlink "> inflammation potential prognostic markers neuronal damage leading modified rankin scale ischemic heart disease ifn -&# 947 derived oxidative stress day functional outcome among sri lankans 9 %, area 100 %, specificity 1 &# 946 poor clinical outcomes improving stroke outcomes acute ischemic stroke 6 &# 8211 48 &# 8211 24 &# 8211 th1 bias polarization 4 phases post th2 bias occurred supplementation may improve ischemic stroke progression th2 cytokine ratio selected serum cytokines fo indicated th1 predicting ais prognosis lower serum il 4 ), vitamin th2 cytokine selected cytokines ratio occurred serum cytokine ais progression poor fo lower vitamin 6 h 48 h 24 h 4 ),serum il phase ),05 ),ais recovery ais prognosis ais patients ais ).serum levels useful biomarkers therapeutic targets significant predictors recovery phase mrs ).may serve matched controls higher il good fo competitive elisa biomarker panel assessed using 98 ).96 h 05 ).001 ).

Licence

CC BY 4.0

Comparison of the performance of the prognostic marker panel (10 –fold cross validation [CV] and permutated model), generated using CV test for the best combos of prognostic markers.

History

Usage metrics

Categories

Keywords

Licence

Exports